Fisetin Dosing Protocol: What the Evidence Says

Photo by Debby Hudson on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated August 2026

Fisetin shows genuine promise as a senolytic compound, meaning it may help clear “zombie” senescent cells that accumulate with age and drive chronic inflammation. But as of 2026, the honest answer about fisetin dosing protocol specifics is this: the human evidence is early, the optimal dose and schedule are not yet confirmed, and most of the dramatic results people reference come from mouse studies. That doesn’t mean fisetin is useless. It means you should know exactly what the research supports before spending money on it.

What Is Fisetin and Why Are Longevity Researchers Interested?

Fisetin is a polyphenol flavonoid found naturally in strawberries (the richest source), apples, persimmons, onions, and cucumbers. At typical dietary amounts, it’s unremarkable. At pharmacological doses, it behaves differently.

The interest in fisetin centers on its classification as a senolytic: a compound that selectively encourages senescent cells to undergo apoptosis (programmed cell death). Senescent cells are damaged cells that stop dividing but refuse to die. They accumulate with age and pump out inflammatory signals called the senescence-associated secretory phenotype (SASP), which damages surrounding healthy tissue.

Clearing senescent cells is one of the more mechanistically compelling targets in longevity research right now. The question isn’t whether the idea is interesting. The question is whether fisetin actually accomplishes this in living humans at safe doses.

What the Research Actually Shows

The Animal Data: Impressive but Not Directly Transferable

The headline study that launched fisetin into the longevity conversation was a 2018 paper from the Mayo Clinic’s Kirkland lab, published in EBioMedicine. In aged mice, fisetin treatment at 100 mg/kg reduced multiple markers of senescent cell burden and extended median lifespan. That 100 mg/kg dose in mice does not translate directly to a human equivalent dose — the math is more complicated than people assume, and mice metabolize compounds very differently than humans do.

To be direct: animal senolytic data is promising enough to justify human trials. It does not, on its own, justify spending significant money on supplements.

The Human Evidence: Small but Real

The most important human study so far was a 2019 pilot trial at Mayo Clinic led by Dr. James Kirkland’s group, involving 14 older adults with frailty. Participants received 20 mg/kg/day of fisetin for two consecutive days. Researchers observed reductions in several circulating senescent cell markers, including p21 and p16 levels. The study was small, it lacked a placebo control arm, and frail elderly patients are not the same population as healthy middle-aged adults taking fisetin preventively.

That said, it established two things: fisetin reaches tissues at these doses, and senescent cell markers do move in the expected direction. Those are meaningful preliminary signals.

A more recent development comes from a 2024 clinical trial protocol published in Trials (PMID: 39434114). The STOP-Sepsis trial is testing fisetin as a senolytic intervention in elderly sepsis patients. The rationale: senescent immune cells may worsen inflammatory responses during sepsis. This trial is testing fisetin in a clinical disease context, not healthy aging, but it confirms that major research institutions consider the drug-like dosing of fisetin worth studying in humans. It also reinforces that fisetin’s primary mechanism here is clearing senescent immune cells, not some vague antioxidant effect.

For broader context on senolytics and how they fit into the hallmarks of aging, see our guide on what senolytics are and how they work.

How Fisetin Compares to Other Senolytic Candidates

If you’re comparing fisetin to other autophagy-related interventions, our breakdown of urolithin A vs. fisetin for longevity covers the key differences in mechanism and evidence quality.

The Fisetin Dosing Protocol Most Researchers Use

Here’s the honest framing: no large RCT has confirmed an optimal fisetin dosing protocol for healthy adults seeking longevity benefits. What exists is a handful of pilot studies and a consensus emerging from researchers who are cautiously applying the available data.

The Pulse Dosing Approach (Preferred by Most Researchers)

Because fisetin is thought to act as a senolytic rather than a daily antioxidant, most researchers favor intermittent “pulse” dosing rather than daily supplementation. The logic: you want to trigger a clearance of senescent cells periodically, then let the body recover. You don’t need fisetin circulating every day the way you might with magnesium or omega-3s.

The protocol that appears most often in research-adjacent discussions:

• 500 to 1000 mg per day
• Taken for 2 consecutive days
• Repeated once per month
• Always taken with a fat-containing meal to improve absorption

The 20 mg/kg figure from the Mayo pilot translates to roughly 1,400 mg for a 70 kg (154 lb) adult. Most over-the-counter supplements deliver 100-500 mg capsules. Hitting 1,000-1,500 mg over two days is achievable and stays within the range of doses that appear safe in the limited human data available.

Daily Low-Dose Approach (Less Supported, More Common in Practice)

Some people take 100-200 mg daily. This is closer to what you’d get from a diet very rich in strawberries. There’s no human RCT evidence that daily low-dose fisetin has meaningful senolytic effects in adults. It may have antioxidant and anti-inflammatory properties at this dose, but that’s a much weaker claim than senolytic activity.

Be skeptical of supplement marketing that conflates these two things.

Practical Protocol: What to Actually Do

1. Choose your dose range. Start at 500 mg/day for 2 days. If well-tolerated, you can increase to 1,000 mg/day for the 2-day pulse on subsequent months.
2. Time it with food. Take fisetin immediately after a meal containing fat (olive oil, eggs, avocado). Absorption increases significantly with dietary fat.
3. Frequency. Repeat the 2-day pulse monthly. Some researchers suggest every 4-6 weeks. There is no confirmed optimal interval in 2026.
4. Track your response. If you’re testing this seriously, consider baseline and follow-up inflammatory markers (hs-CRP, IL-6) through your doctor. These aren’t perfect senescence proxies but give you something to measure.
5. Check for interactions. Fisetin inhibits certain cytochrome P450 enzymes. If you take prescription medications — especially blood thinners, statins, or immunosuppressants — speak with your doctor first.

Bioavailability: The Problem Nobody Talks About Enough

Fisetin has poor oral bioavailability. A meaningful fraction of what you swallow is metabolized before it reaches your tissues. This is a real limitation, not a minor footnote. Some supplement companies are exploring liposomal or nanoparticle fisetin formulations to address this, but as of 2026, most products on the market are standard capsule forms.

Taking fisetin with fat is the most practical evidence-based workaround currently available. The pharmacokinetic data consistently supports better absorption when taken with dietary fat compared to fasting conditions.

This bioavailability issue is also why the mouse-to-human dose translation is difficult. Mice metabolize fisetin much faster than humans do, and their gut microbiome handles it differently.

What We Don’t Know Yet

Honesty matters here. As of August 2026, fisetin research has not answered these questions:

• Does pulse-dosed fisetin reduce senescent cell burden in healthy, non-frail adults?
• What is the truly optimal dose and interval for a 45-year-old taking it preventively?
• Does fisetin meaningfully slow biological aging in humans over years of use?
• Are there long-term risks from repeatedly pushing senescent cells toward apoptosis in otherwise healthy people?
• Which biomarkers best predict individual response to fisetin?

The ongoing trials (including STOP-Sepsis and several Mayo Clinic aging studies) should provide better answers over the next 2-3 years. Until then, fisetin sits in the “promising but unconfirmed” category alongside several other longevity interventions covered in our 2026 longevity supplement evidence review.

For a broader picture of how senolytic compounds fit into the biology of aging, the NIH National Institute on Aging maintains updated summaries of active senescence research that are worth bookmarking.

Safety and Side Effects

The available human data suggest fisetin is reasonably well-tolerated at doses up to 20 mg/kg over 2 days. No serious adverse events were reported in the Mayo pilot. However, the sample sizes are small, follow-up periods were short, and long-term safety data in healthy adults simply don’t exist yet.

Known considerations include:

• Potential drug interactions via CYP450 enzyme inhibition (particularly CYP3A4 and CYP2C9)
• Possible mild GI discomfort at higher doses
• Theoretical concern that aggressive senolytic activity could interfere with wound healing, since some senescent cells play roles in tissue repair
• No established safety data in pregnancy or breastfeeding

For comprehensive evidence on fisetin’s supplement pharmacology, Examine.com maintains regularly updated pages on fisetin’s mechanisms, interactions, and dosing data.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only include products that hold up to our reading of the available evidence. Learn more.

Frequently Asked Questions

What is the best fisetin dosing protocol for longevity?

The protocol most aligned with current research is a pulse-dose approach: 500-1,000 mg per day for two consecutive days, repeated monthly. This is based on the dosing logic from the 2019 Mayo Clinic pilot study and is not yet confirmed by a large randomized controlled trial in healthy adults. Always take fisetin with a fat-containing meal to improve absorption.

Is fisetin safe to take long-term?

Short-term safety data from small human trials look reassuring at doses up to approximately 20 mg/kg over 2 days. Long-term safety data in healthy adults does not yet exist as of 2026. People taking prescription medications should consult a doctor first, as fisetin inhibits certain liver enzymes (CYP3A4 and CYP2C9) that affect drug metabolism.

How much fisetin do you get from food?

Strawberries contain roughly 160 mcg of fisetin per gram, making them the richest dietary source. To reach even 100 mg of fisetin from strawberries alone, you’d need to eat well over a pound of them daily. Dietary fisetin is meaningful for general flavonoid intake but falls far short of the doses used in senolytic research.

Does fisetin need to be taken every day?

No. Researchers favor intermittent pulse dosing rather than daily supplementation. Fisetin is hypothesized to work as a senolytic during the dosing window, triggering senescent cell clearance. Daily low-dose use is popular but lacks evidence for meaningful senolytic activity at typical over-the-counter capsule doses.

How does fisetin compare to quercetin for senolytic effects?

Both are flavonoids with senolytic properties, but fisetin has shown stronger senolytic activity in preclinical comparisons. Quercetin is most often studied as part of the dasatinib plus quercetin combination (D+Q), which has more human trial data but requires a prescription drug component. Fisetin is accessible over the counter and has a favorable safety profile in the limited human data available.

Can I take fisetin with other longevity supplements?

Fisetin is commonly combined with NAD+ precursors, omega-3s, and foundational nutrients without apparent interaction issues in available research. However, combining multiple supplements with overlapping CYP450 inhibition (such as resveratrol or certain quercetin products) may compound drug interaction risk. Discuss your full supplement stack with a healthcare provider if you take any prescription medications.